Nonhormonal therapy for endometriosis: a randomized, placebo-controlled, pilot study of cabergoline versus norethindrone acetate

OBJECTIVE: To estimate the efficacy and safety of a novel nonhormonal therapeutic agent, cabergoline, compared with that of the standard clinical therapy, norethindrone acetate (NETA), for the treatment of endometriosis-associated pain in young women with endometriosis. DESIGN: Randomized, double-bl...

Descripción completa

Detalles Bibliográficos
Autores principales: DiVasta, Amy D., Stamoulis, Catherine, Gallagher, Jenny Sadler, Laufer, Marc R., Anchan, Raymond, Hornstein, Mark D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655411/
https://www.ncbi.nlm.nih.gov/pubmed/34934987
http://dx.doi.org/10.1016/j.xfre.2021.07.003

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8655411/
https://www.ncbi.nlm.nih.gov/pubmed/34934987
http://dx.doi.org/10.1016/j.xfre.2021.07.003

Ejemplares similares